Your First 90 Days on Wegovy: What the Average Looks Like, Week by Week

Your First 90 Days on Wegovy: What the Average Looks Like, Week by Week

A week-by-week map of the first 90 days on Wegovy: what the trials showed, what to watch for, what to eat, how to move, and what a good outcome looks like.

The short version

The first 90 days on Wegovy are the starter block: three months, three dose steps, one month at each. They are not where most of the weight comes off. They are where your body learns the medicine, your appetite changes, and the habits that carry the next year get set. In the largest Wegovy trial, people had lost about 6 percent of their body weight by week 12, on the way to about 15 percent at 68 weeks [1][2]. For someone starting at 215 pounds, that is roughly 13 pounds by day 90, and roughly 32 pounds by the end of the trial.

Everyone is different, and your provider adjusts the plan to you. But it helps to know what average looks like, so you can see yourself in it, know what is normal, and know what to do at each step. This is that map. Read it as the control case: a member who starts, follows the plan, tolerates the steps, and lands on the trial average. Then we look at what that average means for your body and your life after day 90.

The trial numbers behind this map

The reference point is STEP 1, the 68-week trial that led to Wegovy's approval for weight management. Adults with obesity, or overweight with a weight-related condition, took semaglutide 2.4 mg weekly alongside a reduced-calorie diet and increased physical activity. On average they lost about 15 percent of their body weight, against about 2.4 percent for people on placebo with the same diet and activity plan [1]. About one in three lost 20 percent or more [1].

The loss is not a straight line. It is slow in the first month while the dose is low, picks up through months two and three, and runs fastest from month four onward once the dose reaches the maintenance range. By week 12 the average was around 6 percent [2]. That is the number the first 90 days are built around.

Two things the trial asked of everyone, which is why they are part of this plan and not optional extras: a diet with about 500 fewer calories a day than you burn, and about 150 minutes of physical activity a week, with counseling every month [1][5]. The medicine did its part on top of those, not instead of them.

Meet the control case

To make the numbers real, here is an illustrative member. She is made up, but her numbers follow the trial average exactly.

Dana, 41, 5 feet 5 inches, 215 pounds, BMI 35.8. High blood pressure on one medication. She has tried diet and exercise on her own twice and regained both times. Her provider certifies she meets the BMI threshold and checks her history for the two things that rule Wegovy out entirely: a personal or family history of medullary thyroid cancer or the inherited syndrome MEN 2, and a prior serious allergic reaction to semaglutide [4]. She has neither. The provider confirms she is not planning a pregnancy. If she were, the medicine would be stopped at least 2 months before trying, because it stays in the body a long time, and it is not used during pregnancy [4]. She starts on step 1.

  • Day 0, starting. Average loss 0. Dana weighs 215, down 0.
  • Week 4, step 1 (0.25 mg). Average loss about 2 percent. Dana weighs 211, down 4 pounds.
  • Week 8, step 2 (0.5 mg). Average loss about 4 percent. Dana weighs 206, down 9 pounds.
  • Week 12, step 3 (1 mg). Average loss about 6 percent. Dana weighs 202, down 13 pounds.
  • Week 20, on 2.4 mg (maintenance reached about week 17). Average loss about 10 percent. Dana weighs 194, down 21 pounds.
  • Week 68, on 2.4 mg maintenance (lowest weight around week 60). Average loss about 15 percent. Dana weighs 183, down 32 pounds.

Illustrative, based on STEP 1 averages. Week 12 and week 20 are measured points from the trials [1][2][3]; week 4 and week 8 are read from the curve between them and are approximate. The weight curve in STEP 1 reached its low point around week 60 and held from there [1].

Thirteen pounds in 90 days does not sound dramatic, and that is the point. It is steady, it is on a low dose, and it is the runway for the 19 more pounds that follow. Members who expect 20 pounds in the first month get discouraged at exactly the moment the medicine is starting to work.

Week 0: before your first dose

This week is setup, and it decides how smooth month one is.

  • Weigh in and write it down. Same scale, same time of day, once a week from here on. Not daily.
  • Know your call-now symptoms. A lump or swelling in the neck, trouble swallowing, hoarseness, or shortness of breath. Severe upper-stomach pain that spreads to the back with nausea or vomiting, which can be pancreatitis [4]. Fast or pounding heartbeat. A reaction with hives, swelling of the face or throat, or trouble breathing. These are message-now or seek-urgent-care items, not wait-and-see.
  • Set up your food week. Smaller plates, protein at every meal, and a plan for what dinner is before you are hungry. Appetite will change and the easiest wins come from having the right food already in the house.
  • Pick your injection day and put it on a weekly repeat. Same day every week.
  • Tell your provider about every medicine you take, including anything for diabetes. Wegovy slows digestion and can change how oral medicines absorb, and taken with insulin or a sulfonylurea it can cause low blood sugar, so those doses may need lowering [4].

For the full pre-start checklist, see what to know before your first Wegovy dose and the tests and history your provider checks.

Weeks 1 to 4: step 1, 0.25 mg weekly

What is happening. This dose is a starting dose, not a treatment dose. Its job is to let your gut adjust. Appetite usually softens a little. Some people notice nothing at all in week one, and that is normal.

What to watch. Nausea is the main one, usually mild, usually worst a day or two after the injection, and usually settling within the first 2 to 4 weeks [4]. Constipation or loose stools, burping, bloating, and a little fatigue are common. Dana feels queasy the morning after doses one and two, then it fades.

What to do about it. Eat smaller meals and stop before you are full. Eat slowly. Avoid greasy or very rich food on injection day and the day after. Sip water through the day. If you vomit or have diarrhea for more than a day, or you cannot keep fluids down, message us the same day, because dehydration is the real risk.

Food. Aim for a modest calorie deficit, about 500 a day below what you burn [1]. Protein first at each meal, then vegetables, then the rest. You will find you cannot finish what you used to. Let that happen.

Movement. Start with walking. Thirty minutes, five days a week, gets you to the 150 minutes the trial asked for [1]. You do not need a gym. You need a route.

Dana at week 4: 211 pounds. Down 4. Nausea gone. Eating about two thirds of her old portions without trying.

Weeks 5 to 8: step 2, 0.5 mg weekly

What is happening. The dose doubles and appetite suppression becomes obvious. Many members describe the food noise going quiet. Cravings drop. Fullness arrives early and stays.

What to watch. Each step up can bring a short return of nausea for a few days, then it settles again. Constipation becomes more common as you eat less, so fiber and water matter more now, not less. Watch for dizziness on standing, which can mean you are not drinking enough. If you take blood pressure medicine, as Dana does, tell your provider if you feel lightheaded, because weight loss can lower blood pressure and the dose may need adjusting.

What to do about it. If a step is rough, the label allows delaying the next step by 4 weeks [4]. That shifts your calendar, it does not change the ladder, and it is a normal call your provider makes with you. Do not skip ahead and do not double a dose.

Food. This is the month to protect muscle. With appetite this low it is easy to under-eat protein. Keep it at every meal. Add a protein-forward snack if you are skipping meals entirely.

Movement. Keep the walking. Add two short strength sessions a week, bodyweight or light weights, 20 minutes each. Losing weight without resistance work loses muscle along with fat, and muscle is what keeps the weight off later.

Dana at week 8: 206 pounds. Down 9. Clothes looser. She notices she walks up the stairs at work without thinking about it.

Weeks 9 to 12: step 3, 1 mg weekly

What is happening. The last step of the starter block. Appetite is now reliably low and weight loss is steady week to week. This is where members start to believe it.

What to watch. The same brief bump of nausea at the step, then calm. Two things to be alert to at this dose and beyond: gallbladder symptoms, meaning pain in the upper right abdomen especially after eating, and any severe persistent stomach pain, especially pain that spreads to the back, which can be pancreatitis [4]. Both are message-now items. Hair shedding can show up around now in some people. It is usually temporary and linked to rapid weight change, and it is worth mentioning at your review.

What to do about it. Keep fluids up, keep meals small and regular. If you are skipping meals entirely, that is a sign to add structure back, not a sign of success.

Food. By now the pattern should be set: protein, vegetables, whole foods, modest portions, no need for heroics. Alcohol hits harder on less food, so keep it small and eat first.

Movement. 150 minutes a week of walking or its equivalent, plus two strength sessions. If that is already comfortable, add intensity, not hours.

Dana at week 12: 202 pounds. Down 13, about 6 percent, exactly on the trial curve [2]. Her home blood pressure readings are lower. She sleeps better. Her 90-day review is next.

Day 90: the review, and what happens next

The starter block ends with a review. Your provider looks at four things: what you have lost, how you tolerated each step, whether you are eating and moving in the pattern above, and whether to climb or hold. Most members who are on the curve and tolerating the medicine move into a continuation block, steps 4 and 5, 1.7 mg then 2.4 mg, the maintenance range [4][8]. That is when the fastest loss in the trial happened [1]. The label now also allows a further step, up to 7.2 mg weekly, for people who tolerate 2.4 mg and need more loss. That is a decision for a later block, not the first 90 days [4]. See the full dosing schedule and the follow-up schedule.

If your loss is slower than the curve, that is not failure and it is not unusual. It is information. Sometimes the answer is the next dose step. Sometimes it is the food or the movement. Sometimes there is a medicine or a condition getting in the way. That is what the review is for.

What 15 percent means for your body

Dana's trajectory takes her from 215 to about 183 pounds over the trial period. Here is what a loss like that tends to do, based on what the trials measured and what your provider will be watching for.

  • Blood pressure tends to fall, by about 6 points on the top number in the trials [7]. Members on blood pressure medicine often need it reduced.
  • Blood sugar and A1c improve, and for people with prediabetes in STEP 1, 84 percent had normal glucose readings by week 68, against 48 percent on placebo [6].
  • Waist size drops, by about 5 inches on average in the trials [7], and with it the fat around the organs that drives a lot of the risk.
  • Joints carry less load, especially the knees, hips, and lower back.
  • Sleep often improves, and snoring or sleep apnea symptoms can ease.
  • Energy and mobility change in ways that are hard to measure and easy to feel. Stairs, walks, getting off the floor, keeping up with kids.

None of this is a promise. It is what the average looked like, and the average was a real improvement in the numbers that predict heart disease and diabetes, not just a smaller number on the scale.

What 15 percent means for your goals

Set your goal in the trial's terms and it becomes reachable. At 215 pounds, 10 percent is 21 pounds and 15 percent is 32. Those are the numbers to write down, with a date next to each based on the curve above. Then the plan is not "lose weight." It is "reach 194 by week 20 and 183 by the end of the year, by following the steps, eating the pattern, and moving 150 minutes a week." That is a plan you can be seen against, and it is what your check-ins measure.

Wegovy is a long-term treatment for a long-term condition. The trials showed that stopping the medicine tends to bring weight back [3], so the maintenance conversation starts early, not at the end. See stopping Wegovy and keeping the weight off.

The 90-day plan on one page

  • Every week: one injection, same day. One weigh-in, same scale. 150 minutes of walking or equivalent. Two short strength sessions from week 5.
  • Every meal: protein first, vegetables second, stop before full, water through the day.
  • Every step up: expect a few days of nausea, keep meals small, message if you cannot keep fluids down.
  • Always: the call-now list. Neck lump, trouble swallowing, hoarseness, severe stomach pain to the back, upper right abdominal pain after eating, fast heartbeat, an allergic reaction.
  • Day 90: the review. Climb or hold, adjust the plan, set the next target.

For the medicine itself, start at the complete Wegovy guide. For what your provider tracks along the way, see Wegovy monitoring. If nausea is the thing you are worried about, managing GLP-1 nausea goes deeper, and normal effects vs stop-now warnings draws the line clearly.

What it costs with Well Revolution

$80 for the Limited Treatment Plan. If approved, you will receive a 90 day treatment plan with 7 days a week support. Perfect for first time patients who are trying it out.

Or $90 for the Unlimited Membership. If approved, you will receive 3 months of care with 7 days a week support, plus unlimited prescriptions, lab tests, imaging orders, letters and referrals with same day care, cancel anytime, no fees. Perfect for established patients looking for full care.

Getting started with Well Revolution

The 90 day Limited Treatment Plan is built around exactly this starter block: three dose steps, a check-in at each, and the review at day 90. It is chat-based, reviewed by a licensed provider the same day, no appointment, with support 7 days a week for the nausea days and the questions in between. Message us and we will confirm coverage in your state.

References

  1. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine, 2021. PubMed 33567185
  2. Ghusn W, De la Rosa A, Sacoto D, et al. Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity. JAMA Network Open, 2022. PubMed 36121652
  3. Bergmann NC, Davies MJ, Lingvay I, Knop FK. Semaglutide for the treatment of overweight and obesity: A review. Diabetes, Obesity and Metabolism, 2023. PubMed 36254579
  4. Wegovy (semaglutide) prescribing information. Novo Nordisk, via FDA DailyMed, label updated 2026-06-18. dailymed.nlm.nih.gov
  5. Bald E, Raber H. Semaglutide (Wegovy) for the Treatment of Obesity. American Family Physician, 2023;107(1):90-91. PubMed 36689981
  6. Perreault L, Davies M, Frias JP, et al. Changes in Glucose Metabolism and Glycemic Status With Once-Weekly Subcutaneous Semaglutide 2.4 mg Among Participants With Prediabetes in the STEP Program. Diabetes Care, 2022. PubMed 35724304
  7. Gudzune KA, Kushner RF. Medications for Obesity: A Review. JAMA, 2024. PubMed 39037780
  8. Well Revolution semaglutide titration protocol, approved 2026-08-25 (internal).

Reviewed by PA Michael Rubio, US Medical Director

Seeing a doctor is as easy as sending a text

Concerned, need advice, a prescription, refill or referral?
Text a doctor now